However, ovarian cancer studies have shown that downregulation of OCT4 via RNA interference promotes apoptosis and reduces cancer cell viability [101], indicating that OCT4-targeted interventions may also be promising in the breast and brain. The gene discussed is POU5F1; the disease is ovarian carcinoma.